Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?

Author:

Chiron Catherine12ORCID,Helias Marie3,Kaminska Anna12,Laroche Cecile4,de Toffol Bertrand5ORCID,Dulac Olivier12,Nabbout Rima12,An Isabelle26

Affiliation:

1. Department of Pediatric Neurology; Inserm U1129; Necker-Enfants Malades Hospital; Paris France

2. Reference Center for Rare Epilepsies; APHP; Necker-Enfants Malades Hospital; Paris France

3. ESAT le Val (Center of Readaptation for Adults); Mortagne-au-Perche France

4. Department of Pediatrics; Mother and Child Hospital; Limoges France

5. Department of Neurology; Bretonneau Hospital; Tours France

6. Department of Neurology; APHP; Pitie-Salpetriere Hospital; Paris France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference36 articles.

1. Diacomit. EPAR: product information. 2013 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Product_Information/human/000664/WC500036518.pdf

2. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group;Chiron;Lancet,2000

3. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data;Kassaï;Epilepsia,2008

4. Long-term efficacy and tolerance of stiripentol in severe myoclonic epilepsy of infancy (Dravet's syndrome) [in Frenc];Thanh;Arch Pediatr,2002

5. Stiripentol open study in Japanese patients with Dravet syndrome;Inoue;Epilepsia,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3